col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Molecules
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―06 Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2 Susana A. Llivisaca-Contreras, Jaime Naranjo-Morán, Andrea Pino-Acosta, Luc Pieters, Wim Vanden Berghe, Patricia Manzano, et al. (+3)
2 [GO] 2021―Jun―29 Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19 Ying-Qi Wang, Qing-Sheng Li, Xin-Qiang Zheng, Jian-Liang Lu, Yue-Rong Liang
3 [GO] 2021―Jun―28 Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, Roja Rahimi
4 [GO] 2021―Jun―28 Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes Nadezhda Palko, Maria Grishina, Vladimir Potemkin
5 [GO] 2021―Jun―25 Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach Luis Daniel Goyzueta-Mamani, Haruna Luz Barazorda-Ccahuana, Karel Mena-Ulecia, Miguel Angel Chávez-Fumagalli
6 [GO] 2021―Jun―24 A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov Rambod Abiri, Hazandy Abdul-Hamid, Oksana Sytar, Ramin Abiri, Eduardo Bezerra de Almeida, Surender K. Sharma, et al. (+3)
7 [GO] 2021―Jun―23 Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma Mohammad Hailat, Israa Al-Ani, Mohammed Hamad, Zainab Zakareia, Wael Abu Dayyih
8 [GO] 2021―Jun―21 Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization Ayman Abo Elmaaty, Mohammed I. A. Hamed, Muhammad I. Ismail, Eslam B. Elkaeed, Hamada S. Abulkhair, Muhammad Khattab, Ahmed A. Al-Karmalawy
9 [GO] 2021―Jun―21 Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study Nourhan Hisham Shady, Alaa M. Hayallah, Mamdouh F. A. Mohamed, Mohammed M. Ghoneim, Garri Chilingaryan, Mohammad M. Al-Sanea, et al. (+3)
10 [GO] 2021―Jun―11 Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins Eriko Ohgitani, Masaharu Shin-Ya, Masaki Ichitani, Makoto Kobayashi, Takanobu Takihara, Masaya Kawamoto, et al. (+2)
11 [GO] 2021―Jun―09 A Multidisciplinary Approach to Coronavirus Disease (COVID-19) Aliye Gediz Gediz Erturk, Arzu Sahin, Ebru Bati Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, et al. (+5)
12 [GO] 2021―Jun―09 Transport of Aerosols in Underground Mine Workings in Terms of SARS-CoV-2 Virus Threat Krystian Skubacz, Robert Hildebrandt, Aleksandra Zgórska, Zdzisław Dyduch, Krzysztof Samolej, Adam Smolinski
13 [GO] 2021―Jun―07 Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-CoV-2 Denis O. Shatalov, Stanislav A. Kedik, Ivan S. Ivanov, Anna V. Aydakova, Diana A. Akhmedova, Dmitrii S. Minenkov, et al. (+5)
14 [GO] 2021―Jun―07 Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues Vasiliki Daikopoulou, Panagiotis Apostolou, Sofia Mourati, Ioanna Vlachou, Maria Gougousi, Ioannis Papasotiriou
15 [GO] 2021―Jun―02 Anti-Inflammatory, Antiallergic, and COVID-19 Main Protease (Mpro) Inhibitory Activities of Butenolides from a Marine-Derived Fungus Aspergillus terreus Ibrahim Seyda Uras, Sherif S. Ebada, Michal Korinek, Amgad Albohy, Basma S. Abdulrazik, Yi-Hsuan Wang, et al. (+5)
16 [GO] 2021―May―27 Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries Alon Ben David, Eran Diamant, Eyal Dor, Ada Barnea, Niva Natan, Lilach Levin, et al. (+5)
17 [GO] 2021―May―18 Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants Marko Jukič, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik, Urban Bren
18 [GO] 2021―May―14 Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates Sajad Fakhri, Zeinab Nouri, Seyed Zachariah Moradi, Esra Küpeli Akkol, Sana Piri, Eduardo Sobarzo-Sánchez, et al. (+2)
19 [GO] 2021―May―11 Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability Nikola Gligorijević, Dragana Stanić-Vučinić, Mirjana Radomirović, Marija Stojadinović, Urmila Khulal, Olgica Nedić, Tanja Ćirković Veličković
20 [GO] 2021―May―10 In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Mohamed S. Alesawy, Abdallah E. Abdallah, Mohammed S. Taghour, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly
21 [GO] 2021―Apr―30 The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19 Tatyana A. Kuznetsova, Boris G. Andryukov, Ilona D. Makarenkova, Tatyana S. Zaporozhets, Natalya N. Besednova, Ludmila N. Fedyanina, et al. (+2)
22 [GO] 2021―Apr―30 Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis Federico Vittorio Rossi, Dario Gentili, Enrico Marcantoni
23 [GO] 2021―Apr―30 D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect Romina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo
24 [GO] 2021―Apr―29 Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, Dominika Chalupska, Jana Humpolickova, Evžen Bouřa, et al. (+10)
25 [GO] 2021―Apr―29 In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells Sherif Aly El-Kafrawy, Sayed Sartaj Sohrab, Zeenat Mirza, Ahmed M. Hassan, Fatima Alsaqaf, Esam Ibraheem Azhar
26 [GO] 2021―Apr―20 An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor Negin Forouzesh, Nikita Mishra
27 [GO] 2021―Apr―12 Molecular Dynamic Simulation Search for Possible Amphiphilic Drug Discovery for Covid-19 Umer Daood, Divya Gopinath, Malikarjuna Rao Pichika, Kit-Kay Mak, Liang Lin Seow
28 [GO] 2021―Apr―12 Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study Shafi Mahmud, Gobindo Kumar Paul, Mirola Afroze, Shirmin Islam, Swagota Briti Ray Gupt, Mamudul Hasan Razu, et al. (+9)
29 [GO] 2021―Apr―09 Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2 Md. Asraful Alam, Roberto Parra-Saldivar, Muhammad Bilal, Chowdhury Alfi Afroze, Md. Nasir Ahmed, Hafiz M.N. Iqbal, Jingliang Xu
30 [GO] 2021―Apr―09 Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor Norbert Odolczyk, Ewa Marzec, Maria Winiewska-Szajewska, Jarosław Poznański, Piotr Zielenkiewicz
31 [GO] 2021―Apr―05 In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Tarik A. Mohamed, Mohamed A. M. Atia, Montaser A. M. Al-Hammady, Khlood A. A. Abdeljawaad, et al. (+8)
32 [GO] 2021―Mar―30 The Inhibitory Effects of Plant Derivate Polyphenols on the Main Protease of SARS Coronavirus 2 and Their Structure-Activity Relationship Thi Thanh Hanh Nguyen, Jong-Hyun Jung, Min-Kyu Kim, Sangyong Lim, Jae-Myoung Choi, Byoungsang Chung, et al. (+2)
33 [GO] 2021―Mar―29 Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform Kaushik Chakravarty, Victor G. Antontsev, Maksim Khotimchenko, Nilesh Gupta, Aditya Jagarapu, Yogesh Bundey, et al. (+3)
34 [GO] 2021―Mar―22 Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities Salar Hafez Ghoran, Mohamed El-Shazly, Nazim Sekeroglu, Anake Kijjoa
35 [GO] 2021―Mar―22 Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2 Arumugam Vijaya Anand, Balasubramanian Balamuralikrishnan, Mohandass Kaviya, Kathirvel Bharathi, Aluru Parithathvi, Meyyazhagan Arun, et al. (+8)
36 [GO] 2021―Mar―22 Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development Mohamed E. Abouelela, Hamdy K. Assaf, Reda A. Abdelhamid, Ehab S. Elkhyat, Ahmed M. Sayed, Tomasz Oszako, et al. (+3)
37 [GO] 2021―Mar―12 Receptor-Based Pharmacophore Modeling in the Search for Natural Products for Covid-19 Mpro Mohd Saeed, Amir Saeed, Md. Jahoor Alam, Mousa Alreshidi
38 [GO] 2021―Mar―08 Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme Sajjad Ahmad, Yasir Waheed, Saba Ismail, Saadia Bhatti, Sumra Wajid Abbasi, Khalid Muhammad
39 [GO] 2021―Mar―05 SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome Anna Maria Sardanelli, Camilla Isgrò, Luigi Leonardo Palese
40 [GO] 2021―Feb―26 Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies Amira Mohammed Ali, Hiroshi Kunugi
41 [GO] 2021―Feb―24 EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, Madhu M. Ouseph, Anil K. Singh
42 [GO] 2021―Feb―23 Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach Christian R. Gomez, Ingrid Espinoza, Fazlay S. Faruke, Md. Mahbub Hasan, Khondaker Miraz Rahman, Larry A. Walker, Ilias Muhammad
43 [GO] 2021―Feb―22 Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease Roxanna Hajbabaie, Matthew T. Harper, Taufiq Rahman
44 [GO] 2021―Feb―19 In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2 Sebastián A. Cuesta, José R. Mora, Edgar A. Márquez
45 [GO] 2021―Feb―14 Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders Roberta Giordo, Angelo Zinellu, Ali Hussein Eid, Gianfranco Pintus
46 [GO] 2021―Feb―14 Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses Nicola Borbone, Gennaro Piccialli, Giovanni Nicola Roviello, Giorgia Oliviero
47 [GO] 2021―Feb―12 Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors Poonam Kalhotra, Veera C.S.R. Chittepu, Guillermo Osorio-Revilla, Tzayhri Gallardo-Velazquez
48 [GO] 2021―Feb―04 Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease Candida Manelfi, Jonas Gossen, Silvia Gervasoni, Carmine Talarico, Simone Albani, Benjamin Joseph Philipp, et al. (+5)
49 [GO] 2021―Jan―31 COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds Oksana Sytar, Marian Brestic, Shokoofeh Hajihashemi, Milan Skalicky, Jan Kubeš, Laura Lamilla-Tamayo, et al. (+3)
50 [GO] 2021―Jan―30 In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches Alonso Vivar-Sierra, María José Araiza-Macías, José Patricio Hernández-Contreras, Arely Vergara-Castañeda, Gabriela Ramírez-Vélez, Rodolfo Pinto-Almazán, et al. (+2)
51 [GO] 2021―Jan―28 Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism Riadh Badraoui, Mohd Adnan, Fevzi Bardakci, Mousa M. Alreshidi
52 [GO] 2021―Jan―28 Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2 Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad, Guanglin Li
53 [GO] 2021―Jan―26 Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets Isabella Romeo, Francesco Mesiti, Antonio Lupia, Stefano Alcaro
54 [GO] 2021―Jan―25 From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy John Matsoukas, Vasso Apostolopoulos, Anthony Zulli, Graham Moore, Konstantinos Kelaidonis, Kalliopi Moschovou, Thomas Mavromoustakos
55 [GO] 2021―Jan―19 Natural and Nature-Derived Products Targeting Human Coronaviruses Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Michael N. Alexis, Alexios-Leandros Skaltsounis
56 [GO] 2020―Dec―31 The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities Xiao Cong Pang, Han Xu Zhang, Zhi Zhang, Suguro Rinkiko, Yi Min Cui, Yi Zhun Zhu
57 [GO] 2020―Dec―29 Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity Leonardo Lupacchini, Fabrizio Maggi, Carlo Tomino, Chiara De Dominicis, Cristiana Mollinari, Massimo Fini, et al. (+3)
58 [GO] 2020―Dec―25 Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology Zhi-Ling Zhu, Xiao-Dan Qiu, Shuo Wu, Yi-Tong Liu, Ting Zhao, Zhong-Hao Sun, et al. (+2)
59 [GO] 2020―Dec―23 COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far Mujeeb Khan, Syed F. Adil, Hamad Z. Alkhathlan, Muhammad N. Tahir, Sadia Saif, Merajuddin Khan, Shams T. Khan
60 [GO] 2020―Dec―23 Anomaly Identification during Polymerase Chain Reaction for Detecting SARS-CoV-2 Using Artificial Intelligence Trained from Simulated Data Reynaldo Villarreal-González, Antonio J. Acosta-Hoyos, Jaime A. Garzon-Ochoa, Nataly J. Galán-Freyle, Paola Amar-Sepúlveda, Leonardo C. Pacheco-Londoño
61 [GO] 2020―Dec―17 Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment Bwalya A. Witika, Pedzisai A. Makoni, Larry L. Mweetwa, Pascal V. Ntemi, Melissa T. R. Chikukwa, Scott K. Matafwali, et al. (+4)
62 [GO] 2020―Dec―15 Pandemic-Driven Development of a Medical-Grade, Economic and Decentralized Applicable Polyolefin Filament for Additive Fused Filament Fabrication Felix Burkhardt, Carl G. Schirmeister, Christian Wesemann, Massimo Nutini, Stefano Pieralli, Erik H. Licht, et al. (+4)
63 [GO] 2020―Dec―14 Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction Mohammed Sikander, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, et al. (+3)
64 [GO] 2020―Dec―14 Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? Giovanna Giovinazzo, Carmela Gerardi, Caterina Uberti-Foppa, Lucia Lopalco
65 [GO] 2020―Dec―14 Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features Sk. Sarif Hassan, Shinjini Ghosh, Diksha Attrish, Pabitra Pal Choudhury, Alaa A. A. Aljabali, Bruce D. Uhal, et al. (+18)
66 [GO] 2020―Dec―11 The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients Alessandro G. Fois, Panagiotis Paliogiannis, Valentina Scano, Stefania Cau, Sergio Babudieri, Roberto Perra, et al. (+9)
67 [GO] 2020―Dec―11 Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury Lúcio Ricardo Leite Diniz, Marilia Trindade de Santana Souza, Allana Brunna Sucupira Duarte, Damião Pergentino de Sousa
68 [GO] 2020―Dec―11 Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CLpro) Non-Covalent Small-Molecule Inhibitors Marko Jukič, Dušanka Janežič, Urban Bren
69 [GO] 2020―Dec―11 Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2 Amalia Stefaniu, Lucia Pirvu, Bujor Albu, Lucia Pintilie
70 [GO] 2020―Dec―02 Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach Mohd Saeed, Amir Saeed, Md Jahoor Alam, Mousa Alreshidi
71 [GO] 2020―Nov―30 Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein Loai M. Saadah, Ghina’a I. Abu Deiab, Qosay Al-Balas, Iman A. Basheti
72 [GO] 2020―Nov―30 Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study Gema Lizbeth Ramírez-Salinas, Marlet Martínez-Archundia, José Correa-Basurto, Jazmín García-Machorro
73 [GO] 2020―Nov―26 In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2 Yamil Liscano, Jose Oñate-Garzón, Iván Darío Ocampo-Ibáñez
74 [GO] 2020―Nov―24 Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach Teresa L. Augustin, Roxanna Hajbabaie, Matthew T. Harper, Taufiq Rahman
75 [GO] 2020―Nov―24 Alkaloids: Therapeutic Potential against Human Coronaviruses Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, Damião Pergentino de Sousa
76 [GO] 2020―Nov―18 A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 Cecy R Xi, Arianna Di Fazio, Naveed Ahmed Nadvi, Karishma Patel, Michelle Sui Wen Xiang, Hui Emma Zhang, et al. (+12)
77 [GO] 2020―Nov―17 The Role of Vitamin C, Vitamin D, and Selenium in Immune System against COVID-19 Minkyung Bae, Hyeyoung Kim
78 [GO] 2020―Nov―09 Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease Eduardo Tejera, Cristian R. Munteanu, Andrés López-Cortés, Alejandro Cabrera-Andrade, Yunierkis Pérez-Castillo
79 [GO] 2020―Nov―03 Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation Acharya Balkrishna, Siva Kumar Solleti, Sudeep Verma, Anurag Varshney
80 [GO] 2020―Nov―03 Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2 Ahmed Rakib, Saad Ahmed Sami, Md. Ashiqul Islam, Shahriar Ahmed, Farhana Binta Faiz, Bibi Humayra Khanam, et al. (+6)
81 [GO] 2020―Nov―01 In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2 Mathieu Gendrot, Julien Andreani, Priscilla Jardot, Sébastien Hutter, Océane Delandre, Manon Boxberger, et al. (+8)
82 [GO] 2020―Oct―30 Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Kamran Sattar, Suhana Ahmad, Mohd Zulkifli Mustafa, Marcelo De Carvalho Bittencourt, Rohimah Mohamud
83 [GO] 2020―Oct―30 Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies Safaa M. Kishk, Rania M. Kishk, Asmaa S. A. Yassen, Mohamed S. Nafie, Nader A. Nemr, Gamal ElMasry, et al. (+2)
84 [GO] 2020―Oct―17 Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives Camilo Zamora-Ledezma, David F. Clavijo C., Ernesto Medina, Federico Sinche, Nelson Santiago Vispo, Si Amar Dahoumane, Frank Alexis
85 [GO] 2020―Oct―17 High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor Alistair S. Brown, David F. Ackerley, Mark J. Calcott
86 [GO] 2020―Oct―17 Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein-Human ACE2 Receptor Interface Wojciech Płonka, Agata Paneth, Piotr Paneth
87 [GO] 2020―Oct―17 Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study Rajveer Singh, Anupam Gautam, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Syamal Roy, et al. (+2)
88 [GO] 2020―Oct―07 Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro) Sraa Abu-Melha, Mastoura M. Edrees, Sayed M. Riyadh, Mohamad R. Abdelaziz, Abdo A. Elfiky, Sobhi M. Gomha
89 [GO] 2020―Sep―25 Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19 Dun-Xian Tan, Ruediger Hardeland
90 [GO] 2020―Sep―24 Peptides: Prospects for Use in the Treatment of COVID-19 Vladimir Khavinson, Natalia Linkova, Anastasiia Dyatlova, Boris Kuznik, Roman Umnov
91 [GO] 2020―Sep―11 Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction Danuta Witkowska
92 [GO] 2020―Sep―08 Polyphenols vs. Coronaviruses: How Far Has Research Moved Forward? Simona Piccolella, Giuseppina Crescente, Shadab Faramarzi, Marialuisa Formato, Maria Tommasina Pecoraro, Severina Pacifico
93 [GO] 2020―Sep―07 The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents Gustavo R. Villas-Boas, Vanessa C. Rescia, Marina M. Paes, Stefânia N. Lavorato, Manoel F. de Magalhães-Filho, Mila S. Cunha, et al. (+21)
94 [GO] 2020―Aug―28 Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19 Ahmed Rakib, Arkajyoti Paul, Md. Nazim Uddin Chy, Saad Ahmed Sami, Sumit Kumar Baral, Mohuya Majumder, et al. (+8)
95 [GO] 2020―Aug―24 In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection R.P. Vivek-Ananth, Abhijit Rana, Nithin Rajan, Himansu S. Biswal, Areejit Samal
96 [GO] 2020―Aug―24 Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method Milan Sencanski, Vladimir Perovic, Snezana B. Pajovic, Miroslav Adzic, Slobodan Paessler, Sanja Glisic
97 [GO] 2020―Aug―17 Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study Stefania Mazzini, Loana Musso, Sabrina Dallavalle, Roberto Artali
98 [GO] 2020―Jul―30 Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections Daniel P. Otto, Melgardt M. de Villiers
99 [GO] 2020―Jul―22 High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2 Olujide O. Olubiyi, Maryam Olagunju, Monika Keutmann, Jennifer Loschwitz, Birgit Strodel
100 [GO] 2020―Jun―30 Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1 Olga Tarasova, Sergey Ivanov, Dmitry A. Filimonov, Vladimir Poroikov
101 [GO] 2020―Jun―16 Potential of Flavonoid-Inspired Phytomedicines against COVID-19 Wilfred Ngwa, Rajiv Kumar, Daryl Thompson, William Lyerly, Roscoe Moore, Terry-Elinor Reid, et al. (+2)
102 [GO] 2020―Jun―03 In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus Phaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou, Athina Geronikaki
103 [GO] 2020―May―22 Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming Elisa Barile, Carlo Baggio, Luca Gambini, Sergey A. Shiryaev, Alex Y. Strongin and Maurizio Pellecchia
104 [GO] 2020―May―20 Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E) Keykavous Parang, Naglaa Salem El-Sayed, Assad J. Kazeminy, Rakesh K. Tiwari
105 [GO] 2020―May―12 Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) Noor Rahman, Zarrin Basharat, Muhammad Yousuf, Giuseppe Castaldo, Luca Rastrelli, Haroon Khan
106 [GO] 2020―Apr―29 Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease Carmen Ciavarella, Ilenia Motta, Sabrina Valente, Gianandrea Pasquinelli
107 [GO] 2020―Apr―21 Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight Inès Thabti, Quentin Albert, Stéphanie Philippot, François Dupire, Brenda Westerhuis, Stéphane Fontanay, et al. (+5)
108 [GO] 2020―Apr―16 COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help Giovanni Lentini, Maria Maddalena Cavalluzzi, Solomon Habtemariam
109 [GO] 2020―Apr―15 Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses Nakarin Suwannarach, Jaturong Kumla, Kanaporn Sujarit, Thanawat Pattananandecha, Chalermpong Saenjum, Saisamorn Lumyong


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec